SC

Sapkale Chandrakant Raoji

Active Director Director DIN 08084523
DIN 08084523 First appointment Mar 2018 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Sapkale Chandrakant Raoji

Data last updated:

Sapkale Chandrakant Raoji is a Director at Nirmalchandra Multispeciality Private Limited (since 2018). The company operates in Healthcare.

DIN 08084523
Primary Designation Director
Industry Healthcare
First Appointment 13 Mar 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Mar 20182018Active

Directorship timeline

Open interactive timeline →
Nirmalchandra Multispeciality Private Limited
Premium access

Shareholding and investment profile for Sapkale Chandrakant Raoji

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sapkale Chandrakant Raoji

Sapkale Chandrakant Raoji currently holds 1 directorship: Nirmalchandra Multispeciality Private Limited (Director, since 13 Mar 2018).

Sapkale Chandrakant Raoji was first appointed on 13 Mar 2018 as Director at Nirmalchandra Multispeciality Private Limited.

The current boards of Sapkale Chandrakant Raoji's companies include Sandeep Chandrakant Sapkale (Nirmalchandra Multispeciality Private Limited), Santosh Kumar Suman (Nirmalchandra Multispeciality Private Limited), Sapkale Pradip Chandrakant (Nirmalchandra Multispeciality Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available